Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation
Biophysical Chemistry · 2023
DOI: 10.1016/j.bpc.2023.107029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biophysical Chemistry, 2023. Verfasst von Asra Nasir Khan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Biotechnology Unit, AMU, Aligarh 202002, India. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Amyloidosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Biotechnology Unit, AMU, Aligarh 202002, India.
- Interdisciplinary Biotechnology Unit, AMU, Aligarh 202002, India. Electronic address: rhkhan.cb@amu.ac.in.
Zitieren
APA
Khan, A. N., Nabi, F., & Khan, R. H. (2023). Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation. Biophysical Chemistry. https://doi.org/10.1016/j.bpc.2023.107029
Vancouver
Khan AN, Nabi F, Khan RH. Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation. Biophysical Chemistry. 2023. doi:10.1016/j.bpc.2023.107029
BibTeX
@article{Khan2023,
author = {Khan, Asra Nasir and Nabi, Faisal and Khan, Rizwan Hasan},
title = {Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation},
journal = {Biophysical Chemistry},
year = {2023},
doi = {10.1016/j.bpc.2023.107029}
}
EUVIMED